Evidence map›Paper›PMID 32147775›Full record

ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2021

The far-reaching HAND of cART: cART effects on astrocytes.

Hemil Gonzalez, Anthony Podany, Lena Al-Harthi, Jennillee Wallace

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Neuroinflammation: From Molecular Basis to Therapy.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Neuropathogenesis of HIV and emerging therapeutic targets.Expert opinion on therapeutic targets · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hemil GonzalezDepartment of Internal Medicine, Division of Infectious Disease, Rush University Medical Center, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-3517-1398
Anthony PodanyDepartment of Pharmacy Practice and Science; College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA.
Lena Al-HarthiDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, USA.
Jennillee WallaceDepartment of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, USA. Jennillee_Wallace@rush.edu.
Rush University Medical Center · USNebraska Medical Center · US

Funding

Dynamic interaction between HIV in the CNS and peripheral organsR01NS108796 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2019 to 2023
$3.7M
Neuroimmune axis in HAND and HIV persistence in the brainR01MH113425 · NIMH · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2017 to 2021
$3.1M
HIV latency in astrocytesR01MH100628 · NIMH · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2013 to 2017
$2.2M
Clinical Pharmacology of Efavirenz Combined with High Dose RifapentineK23AI134307 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PODANY, ANTHONY T · 2018 to 2022
$819k
cART effects on glial cellsR21MH122241 · NIMH · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2020 to 2021
$432k
National Institutes of Health (US) RO1MH113425NIAID NIH HHS K23 AI134307NIMH NIH HHS R01 MH100628NIMH NIH HHS R01 MH113425NIMH NIH HHS R21 MH122241NINDS NIH HHS R01 NS108796
6 · The paper itself

Abstract

Following the introduction of combination antiretroviral therapy (cART), the morbidity and mortality from human immunodeficiency virus (HIV) infection has been drastically curtailed and HIV has now become a chronic manageable disease. Persons living with HIV (PLWH) are living longer and experiencing significant co-morbidities and conditions of aging. NeuroHIV, clinically defined as HIV-Associated Neurocognitive Disorders (HAND) and pathologically manifested by persistent inflammation in the CNS despite cART, is a significant co-morbid condition for PLWH. In the pre-cART era, HIV mediated much of the pathogenesis in the Central Nervous System (CNS); in the cART era, with low to undetectable viremia, other mechanisms may be contributing to persistent neuroinflammation. Emerging data point to the adverse effects at the cellular level of cART, independent of HIV. Astrocytes are the most abundant cells in the CNS, playing vital roles in maintaining CNS homeostasis (e.g. metabolic support to neurons, clearance of neurotransmitters, ion balance, modulation of synaptic functions and maintaining the structural integrity of the blood brain barrier (BBB). Therefore, any disruption of their function will have wide repercussions in the CNS. In this review, we will address current knowledge and gaps on the impact of antiretrovirals (ARVs) on astrocytes and physiologic consequences in the CNS. Understanding the status of this field, will provide a practical framework to elucidate the potential role of cART-mediated dysregulation of astrocytes in neuroHIV pathogenesis and inform therapeutic strategies that are "neuro-friendly". Graphical abstract CNS-penetrating cART have the potential to cause resting astrocytes to become activated into an A1 or neurotoxic phenotype. These cells can in turn secrete inflammatory cytokines that affect surrounding microglia macrophages, as well as neurotoxic factors that impact nearby neurons. In addition, impairment in the physiologic functions of astrocytes will result in altered BBB permeability and disrupted metabolic homeostasis. CNS=Central Nervous System; cART=combined antiretroviral therapy; BBB=blood brain barrier.

Indexed as

AgingAIDS Dementia ComplexAnimalsAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveAstrocytesCalciumCellular SenescenceCentral Nervous SystemGlucoseGlutamic AcidGlutamineHIV-1HIV InfectionsHumansMitochondriaAnti-HIV AgentsCalciumGlucoseGlutamic AcidGlutamineARVsAstrocytescARTHANDNeurotoxicity

Identifiers

PMID32147775
PMCPMC7483784
OpenAlexW3011101528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.